Toxicological evaluation of the humanized Anti-CD6 MAb T1h in Rheumatoid Arthritis Patients. Clinical Trial phase I.
Phase of Trial: Phase I
Latest Information Update: 09 Mar 2017
At a glance
- Drugs Itolizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- 31 Jul 2013 Status changed from active, no longer recruiting to completed as reported by Cuban Clinical Trial Registry.
- 07 Sep 2011 New trial record